ACE Report Cover
Lidocaine injection + physiotherapy comparable to monotherapy for myofascial pain syndrome
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Langue
Download Download Download
Télécharger
Cite this Report Cite this Report Cite this Report
Citer
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoris
Translate this  ACE Report Translate this  ACE Report Translate this  ACE Report
Langue
Download Download Download
Télécharger
Cite this Report Cite this Report Cite this Report
Citer
Add to Favorites Add to Favorites Add to Favorites Remove from Favorites Remove from Favorites Remove from Favorites
+ Favoris

SHOULDER & ELBOW

Treatment of myofascial pain syndrome with lidocaine injection and physical therapy, alone or in combination: a single blind, randomized, controlled clinical trial

OrthoEvidence Journal (OE Journal) - ACE Report

OE Journal. 2016;4(8):24 BMC Musculoskelet Disord. 2016 Feb 24;17(1):101.

Auteurs contributeurs

LH Lugo HI García HL Rogers JA Plata

135 patients with myofascial pain syndrome located in the muscles of the shoulder were randomized to either physical therapy, lidocaine injection, or a combination of physical therapy and lidocaine injection, for the purpose of determining whether combination therapy is more effective than monotherapies for improving pain, function, and quality of life outcomes after 3 months. Results demonstrated that all relevant clinical outcomes were comparable between all study groups at final follow-up, suggesting that the combination of the two monotherapies was equally as effective as its singular components.


Détails du financement de la publication +
Financement:
Non-Industry funded
Sponsor:
University of Antioquia School of Medicine, 2013-2014 Sustainability Strategy of Universidad
Conflits:
None disclosed

Risque de partialité

7/10

Critères de déclaration

18/20

Indice de fragilité

N/A

Was the allocation sequence adequately generated?

Was allocation adequately concealed?

Blinding Treatment Providers: Was knowledge of the allocated interventions adequately prevented?

Blinding Outcome Assessors: Was knowledge of the allocated interventions adequately prevented?

Blinding Patients: Was knowledge of the allocated interventions adequately prevented?

Was loss to follow-up (missing outcome data) infrequent?

Are reports of the study free of suggestion of selective outcome reporting?

Were outcomes objective, patient-important and assessed in a manner to limit bias (ie. duplicate assessors, Independent assessors)?

Was the sample size sufficiently large to assure a balance of prognosis and sufficiently large number of outcome events?

Was investigator expertise/experience with both treatment and control techniques likely the same (ie.were criteria for surgeon participation/expertise provided)?

Oui = 1

Incertain = 0,5

Non pertinent = 0

Non = 0

L'évaluation des critères de rapport permet d'évaluer la transparence avec laquelle les auteurs rapportent les caractéristiques méthodologiques et les caractéristiques de l'essai dans la publication. L'évaluation est divisée en cinq catégories qui sont présentées ci-dessous.

3/4

Randomization

3/4

Outcome Measurements

4/4

Inclusion / Exclusion

4/4

Therapy Description

4/4

Statistics

Detsky AS, Naylor CD, O'Rourke K, McGeer AJ, L'Abbé KA. J Clin Epidemiol. 1992;45:255-65

L'indice de fragilité est un outil qui aide à l'interprétation des résultats significatifs, en fournissant une mesure de la force d'un résultat. L'indice de fragilité représente le nombre d'événements consécutifs qui doivent être ajoutés à un résultat dichotomique pour que le résultat ne soit plus significatif. Un petit nombre représente un résultat plus faible et un grand nombre un résultat plus fort.

Pourquoi cette étude était-elle nécessaire maintenant ?

Myofascial pain syndrome (MPS) is often characterized by the presence of myofascial trigger points (MTrPs) and associated hypersensitive areas that induce pain, tenderness, and autonomic behaviour when manipulated. Current conservative treatments include ultrasound therapy, massage and stretching with aerosolized fluoromethane, and physiotherapy. However, whether or not a superior treatment (or combination of treatments) exists has yet to be determined, and thus, the current study was conducted.

Quelle était la principale question de recherche ?

For patients with myofascial pain syndrome, did the combination of physical therapy and lidocaine injection (without epinephrine) demonstrate significantly improved pain ratings, function, quality of life, and depressive symptoms when compared to physical therapy or lidocaine injection alone, as assessed up to 3 months post-intervention?

Caractéristiques de l'étude +
Population:
135 patients with myofascial trigger points (MTrPs) in the trapezius, the infraspinatus, and/or the levator scapulae were included in this study. Patients were required to have neck or shoulder pain last for more than 6 weeks prior to study initiation and have a pain score equal to or greater than 40 on a visual analogue scale (VAS) for pain.
Intervention:
PT+LI group: patients received combination therapy of both physical therapy and lidocaine injection of 0.2 mL 0.5% lidocaine via a 25 or 26 gauge needle at an angle of 30 degrees into the MTrP and surrounding subcutaneous tissue. (n=45, 41 completed follow-up; mean age= 37.2+/-11.1, M=6/F=32).
Comparaison:
PT group: patients received physical therapy only. Physical therapy included 12 sessions (1-hour sessions, 3 times per week for 4 weeks) involving 10 minutes of hot pack and ultrasound therapy followed by deactivation of MTrPs by manual compression for 10 minutes and stretches specific to the muscle that was affected. (n=45, 43 completed follow-up; mean age= 42.6+/-9.7, M=7/F=36). LI group: patients received lidocaine injection therapy alone (described above) (n=45, 43 completed follow-up; mean age= 37.7+/-11.8, M=10/F=33).
Résultats:
Primary outcome measure included pain measured via a visual analogue scale (VAS) 1 month post-intervention. Secondary outcomes included VAS pain at 3 months post-intervention, and function (evaluated by the hand-back/hand-mouth maneuver), quality of life measured by SF-36, and depression symptoms measured by the Patient Health Questionnaire-9 (PHQ-9) at both 1 months and 3 months post intervention.
Méthodes:
RCT: assessor-blinded, multi-centre
Durée de l'intervention:
Evaluations were made at 1-month and 3-months post-intervention.

Quels sont les résultats importants ?

  • VAS pain scores measured 1-month post-intervention were similar when patients who received combination therapy (PT+LI) were compared to patients who received physical therapy alone (PT group, p=0.56) and those who received lidocaine injection therapy alone (LI group, p=0.545).
  • PHQ-9 and SF-36 subscale (measuring depression symptoms and quality of life, respectively) differences between groups were not significant after one-month post-treatment. When SF-36 subscales were analyzed individually, patients in the PT+LI group recorded significant improvements in health when compared to patients in the PT group (p=0.03). No statistical difference was observed between the LI group and the PT+LI group.
  • VAS pain scores, PHQ-9 scores, and SF-36 scores were comparable between all study groups when measured at 3 months post-intervention (p>0.05).
  • Right upper limb hand-back maneuver scores for patients in the PT and PT+LI groups were significantly higher when compared to patients who received LI therapy alone (p=0.013,p=0.016 respectively) at 1 month and 3 months post-intervention. Left upper limb hand-back maneuver scores, we well as hand-mouth maneuver scores were comparable between all study group at all follow-up points.
  • Analgesic use was comparable between patients in all study groups. 4 patients in the PT+LI group and 2 patients in the LI group experienced localized hematomas. One participant in the LI group reported minimal bleeding; there were no complications recorded in the PT group.
De quoi dois-je me souvenir en priorité ?

For patients with myofascial pain syndrome (MPS), treatment via physiotherapy alone, lidocaine injection therapy alone, or combination therapy (physiotherapy and lidocaine injection) resulted in comparable outcomes at all relevant primary and secondary measures when measured at one and three months post-treatment.

Comment cela affectera-t-il les soins prodigués à mes patients ?

The results of this study suggest that physical therapy and lidocaine injection combination therapy may be similarly effective in improving pain, function, and quality of life outcomes when compared to patients who received either monotherapy at all follow-up points. Future randomized controlled trials with larger patient populations and more patient-focused functional outcomes should be conducted in order to corroborate this study's findings.

AVIS DE NON-RESPONSABILITÉ

Le contenu de cette page est fourni à titre d'information uniquement et n'est pas destiné à remplacer un avis médical, un diagnostic ou un traitement professionnel. Si vous avez besoin d'un traitement médical, demandez toujours l'avis de votre médecin ou rendez-vous au service des urgences le plus proche. Les opinions, croyances et points de vue exprimés par les individus sur le contenu de cette page ne reflètent pas les opinions, croyances et points de vue d'OrthoEvidence.

0 de 4 articles mensuels GRATUITS débloqués
Vous avez atteint votre limite de 4 vues d'articles gratuits ce mois-ci

Accédez à OrthoEvidence pour seulement 1,99 $ par semaine.

Restez informé des dernières données. Annulez à tout moment.
  • Évaluations critiques des derniers essais contrôlés randomisés à fort impact et des revues systématiques en orthopédie.
  • Accès au contenu des podcasts OrthoEvidence, y compris les collaborations avec le Journal of Bone and Joint Surgery, les entretiens avec des chirurgiens de renommée internationale et les tables rondes sur l'actualité et les sujets orthopédiques.
  • Abonnement à The Pulse, une lettre d'information bihebdomadaire fondée sur des données probantes, conçue pour vous aider à prendre de meilleures décisions cliniques.
Upgrade
Close Dialog
Bienvenue à nouveau !
Vous avez oublié votre mot de passe ?
Commencez votre essai GRATUIT dès aujourd'hui !

Votre compte sera affilié à
et inclut un accès gratuit à OrthoEvidence.


OU
Vous avez oublié votre mot de passe ?

OU
Veuillez vérifier votre adresse électronique

Si un compte existe avec l'adresse e-mail fournie, un e-mail de réinitialisation du mot de passe vous sera envoyé. Si vous ne voyez pas d'e-mail, veuillez vérifier votre dossier de spam ou de courrier indésirable.

Pour plus d'assistance, contactez notre équipe d'assistance.

Veuillez vous connecter pour activer cette fonction

Pour accéder à cette fonctionnalité, vous devez être connecté à un compte OrthoEvidence actif. Veuillez vous connecter ou créer un compte d'essai GRATUIT.

Traduire le rapport ACE

OrthoEvidence utilise un service de traduction tiers pour rendre le contenu accessible dans plusieurs langues. Veuillez noter que même si tous les efforts sont faits pour assurer l'exactitude, les traductions ne sont pas toujours parfaites.

Comment citer ce document ACE Report

OrthoEvidence. Lidocaine injection + physiotherapy comparable to monotherapy for myofascial pain syndrome. OE Journal. 2016;4(8):24. Available from: https://myorthoevidence.com/AceReport/Show/lidocaine-injection-physiotherapy-comparable-to-monotherapy-for-myofascial-pain-syndrome

Copier la citation
Veuillez vous connecter pour activer cette fonction

Pour accéder à cette fonctionnalité, vous devez être connecté à un compte OrthoEvidence actif. Veuillez vous connecter ou créer un compte d'essai GRATUIT.

Fonctionnalité Membre Premium

Pour accéder à cette fonctionnalité, vous devez être connecté à un compte Premium OrthoEvidence.

Partager ACE Report